Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bioblast Pharma Ltd (NASDAQ:ORPN)

1.11
Delayed Data
As of Jan 23
 -0.05 / -4.31%
Today’s Change
0.92
Today|||52-Week Range
7.95
+6.73%
Year-to-Date

Today’s Trading

Previous close1.16
Today’s open1.17
Day’s range1.08 - 1.18
Volume28,931
Average volume (3 months)58,684
Market cap$19.0M
Dividend yield--
Data as of 01/23/2017

Growth & Valuation

Earnings growth (last year)-89.47%
Earnings growth (this year)+2.78%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book0.92

Competitors

 Today’s
change
Today’s
% change
DRIODarioHealth Corp-0.02-0.63%
APTOAptose Biosciences I...-0.24-18.32%
APOPCellect Biotechnolog...-0.28-7.33%
WGBSWaferGen Bio-systems...+0.18+3.24%
Data as of 01/23/2017

Financials

Next reporting dateFebruary 21, 2017
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$0.00
Annual profit (last year)-$15.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman &
Chief Executive Officer
Fredric D. Price
Chief Medical Officer &
VP-Research
Warren W. Wasiewski
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts


Search for Jobs